Skip to main content
. 2022 Dec 20;12:115. doi: 10.1186/s13613-022-01087-5

Table 3.

Univariable and multivariable logistic regression analyses of factors associated with a complicated hospital coursea

N Univariable analysis Multivariable analysis
Non complicated course Complicated course OR [95% CI] P-value aOR [95% CI] P-value
N = 46 N = 123
Demographic data
 Age 169 59 [52–69] 60 [53–68] 1.00 [0.98; 1.03] 0.724
 Sex 169
  Male 31 (67.4) 89 (72.4) 1.32 [0.63; 2.75] 0.459
  Female 15 (32.6) 34 (27.6) Ref
Hospital trajectory data
 Annual NSTI procedural volume < 3/year 169 5 (10.9) 33 (26.8) 3.01 [1.09; 8.26] 0.033
 Type of structure after ICU 167 0.139
  Medical ward 19 (41.3) 66 (54.6) Ref.
  Rehabilitation 5 (10.9) 5 (4.1) 0.29 [0.08; 1.10] 0.069
  Plastic surgery 7 (15.2) 9 (7.4) 0.37 [0.12; 1.13] 0.080
  Other surgical ward 15 (32.6) 41 (33.9) 0.79 [0.36; 1.72] 0.548
 Inter-hospital transfer 167
  No 18 (39.1) 61 (50.4) Ref
  Yes 28 (60.9) 60 (49.6) 0.63 [0.32; 1.26] 0.194
NSTI characteristics
 Hospital-acquired NSTI 169 12 (26.1) 26 (21.1) 0.76 [0.35; 1.67] 0.494
 Topography
  Upper limb 169 7 (15.2) 17 (13.8) 0.89 [0.34; 2.32] 0.817
  Lower limb 169 32 (69.6) 88 (71.5) 1.10 [0.52; 2.31] 0.801
  Abdominal/perineal 169 7 (15.2) 26 (21.1) 1.49 [0.60; 3.72] 0.390
  Multifocal 169 0 2 (1.6)
Comorbidities
 Immunosuppression 169 9 (19.6) 34 (27.6) 1.57 [0.69; 3.60] 0.286
 PAOD 169 6 (13.0) 20 (16.3) 1.29 [0.48; 3.46] 0.607
 Cancer 169 5 (10.9) 9 (7.3) 0.65 [0.20; 2.04] 0.459
 Neutropenia 169 2 (4.4) 3 (2.4) 0.55 [0.09; 3.40] 0.520
 HIV infection 169 0 4 (3.3)
 Diabetes 169 23 (50.0) 71 (57.7) 1.37 [0.69; 2.69] 0.369
 Chronic heart failure 169 11 (23.9) 26 (21.1) 0.85 [0.38; 1.91] 0.698
 COPD 168 5 (10.9) 12 (9.8) 0.89 [0.30; 2.70] 0.843
 Cirrhosis 168 2 (4.4) 13 (10.7) 2.62 [0.57; 12.11] 0.216
 Chronic hemodialysis 169 0 5 (4.1)
 Chronic alcohol use 169 8 (17.4) 41 (33.3) 2.38 [1.01; 5.55] 0.046
 Previous NSAIDs use 167 14 (30.4) 23 (19.0) 0.54 [0.25; 1.16] 0.115
 Obesity 169 13 (28.3) 47 (38.2) 1.57 [0.75; 3.28] 0.231
Microbiological data
 Number of isolated bacteria 156 1 [1, 2] 2 [1–4] 1.38 [1.07; 1.78] 0.014
 NSTI categorization 154
  Type II (monomicrobial) 24 (55.8) 41 (36.9) Ref. Ref.
  Type I (polymicrobial) 19 (44.2) 70 (63.1) 2.16 [1.06; 4.41] 0.035 3.18 [1.37; 735] 0.007
 Positive blood culture 169 6 (13.0) 44 (35.8) 3.71 [1.46; 9.45] 0.006 3.29 [1.14; 9.52] 0.028
 Isolation of multi / highly resistant bacteria 167 3 (6.5) 26 (21.5) 3.92 [1.13; 13.67] 0.032
 Hospital-acquired NSTI 169 12 (26.1) 26 (21.1) 0.76 [0.35; 1.67] 0.494
Severity scores
 SAPS II 161 33 [22–45] 53 [33.5–68] 1.05 [1.02; 1.07]  < 0.001 1.05 [1.02; 1.07]  < 0.001
 SOFA 161 4 [1–7] 9.5 [5–12] 1.09 [1.01; 1.17] 0.022

Qualitative variables are shown as number (percentages) and continuous variables as median [quartile 1-quartile 3]

PAOD peripheral artery occlusive disease, HIV human immunodeficiency virus, COPD chronic obstructive pulmonary disease, NSAIDs non-steroidal anti-inflammatory drugs, NSTI necrotizing soft tissue infection, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment score, OR odds ratio, aOR adjusted odds ratio

aDefined by one of the following: a duration of hospital stay ≥ 6 weeks, a number of debridement performed ≥ 3, or hospital death; Area under the ROC curve = 0.796; model calibration (p = 0.442, Hosmer–Lemeshow test)

Bolded variables are significant at the p < 0.05 level